In triple-negative breast cancer (TNBC), MS4A7 has been identified as a prognostic factor, and a predictive model that incorporates the MS4A7, SPARC, and CD300C genes has demonstrated strong prognostic accuracy (105). Here, MS4A7 is linked to triple-negative breast carcinoma.